About
Nutrition Program to Enhance Cancer Therapy
Areas of Focus
Categories
Non-PharmaceuticalBiotech
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
5
As Collaborator
0
Total Enrollment
120
By Phase
PHASE2: 2NA: 2PHASE1: 1
By Status
COMPLETED: 2RECRUITING: 1TERMINATED: 1WITHDRAWN: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
Hover over trial bars to see details
Recent Trials
NCT06463028Lead Sponsor
Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer
PHASE2Recruiting
40 participants
Started: Dec 12, 2024 · Completed: Sep 30, 2029
NCT05275673Lead Sponsor
A Study of Sapanisertib in Relapsed/Refractory NFE2L2-Mutated and Wild-Type Squamous Non-Small Cell Lung Cancer
PHASE2Terminated
7 participants
Started: Jul 21, 2022 · Completed: Jan 24, 2023
NCT05183295Lead Sponsor
Medical Food for the Dietary Management of Metastatic Colorectal Cancer
NAWithdrawn
Started: Apr 27, 2022 · Completed: Mar 27, 2023
NCT05300048Lead Sponsor
Combination of Serabelisib and Insulin Suppressing Diet With or Without Nab-paclitaxel in Subjects With Advanced Solid Tumors With PIK3CA Mutations
PHASE1Completed
34 participants
Started: Apr 22, 2022 · Completed: Apr 30, 2025
NCT05078775Lead Sponsor
Medical Food for the Dietary Management of Advanced/Metastatic Pancreatic Cancer
NACompleted
39 participants
Started: Dec 21, 2021 · Completed: Jul 10, 2025
Locations (1)
Headquarters
San Francisco, CA, United States
Map
Loading map...